Tag: oncology
-
Experimental Drug Doubles Survival for Metastatic Pancreatic Cancer
A new experimental drug has demonstrated remarkable success, doubling the median survival rate for patients with metastatic pancreatic cancer. This breakthrough offers a dramatic shift in treatment, bringing renewed hope to those affected.
HealthBusinessScience & TechnologyEntertainmentMedical ScienceEconomyEmployment and LaborEducation Pancreatic CancerMetastatic CancerExperimental DrugCancer TreatmentMedical ResearchSurvival RateOncology
-
Yale Uncovers Wildlife Behavior Changes and New Uterine Cancer Treatment
Yale scientists reveal human impact on wildlife behavior and a new targeted chemotherapy for advanced uterine cancer. These breakthroughs highlight Yale's commitment to scientific advancement and its widespread influence.
HealthScience & TechnologyEducationMediaMedical ScienceEnvironmentLegalDigital and Print PublishingSocial Issues Yale Universitywildlifeanimal behavioroncologyuterine cancerpersonalized treatmentscientific researchUniversity
-
Sun Pharma Recalls Doxorubicin Injection Over Glass Particle Risk
Sun Pharmaceutical Industries is recalling a batch of DOXOrubicin Hydrochloride Liposome Injection in the U.S. due to potential glass particles. This recall affects 675 vials, posing risks like blood clots, though no adverse events have been reported.
HealthBusinessPolitics and GovernmentMedical ScienceLegalEducationFederal Government Product RecallPharmaceuticalsOncologyMedication SafetySun Pharmaceutical IndustriesDOXOrubicinFood RecallsFDADrugs
-
Yale Showcases Innovative Research and Unique Educational Opportunities
Yale highlights unique hands-on physics education with a particle accelerator, groundbreaking cancer research, economic history insights for policy, and initiatives fostering human connection, showcasing diverse academic and community engagement.
HealthBusinessScience & TechnologyMediaMedical ScienceEconomyEducationDigital and Print PublishingSocial Issues Yale UniversityHigher EducationPhysicsOncologyEconomicsPaul NoelLajos PusztaiUniversity